New Edge Advisors, LLC Ionis Pharmaceuticals Inc Transaction History
New Edge Advisors, LLC
- $11.2 Billion
- Q1 2024
A detailed history of New Edge Advisors, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 2,025 shares of IONS stock, worth $96,511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,025
Previous 2,088
3.02%
Holding current value
$96,511
Previous $105,000
17.14%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IONS
# of Institutions
396Shares Held
122MCall Options Held
854KPut Options Held
464K-
Vanguard Group Inc Valley Forge, PA13.4MShares$640 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.3MShares$635 Million0.35% of portfolio
-
Black Rock Inc. New York, NY9.77MShares$466 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.3MShares$396 Million5.64% of portfolio
-
Wellington Management Group LLP Boston, MA5.7MShares$271 Million0.04% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.76B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...